for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Tetra Bio-Pharma to file for CTA to initiate Phase 3 clinical trial on terminal cancer patients

Sept 18 (Reuters) - Tetra Bio Pharma Inc

* Tetra Bio-Pharma getting ready to file a Clinical Trial Application to initiate Phase 3 clinical trial on terminal cancer patients in the coming weeks

* Tetra Bio Pharma - with filing of Clinical Trial Application, co expects to be on time with previously announced schedule with development of PPP001

* Tetra Bio Pharma Inc - restructured its investors and public relation functions to integrate them with marketing and communication functions

* Tetra Bio Pharma Inc - Edward Miller is leaving corporation effective as of Sept 18 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up